Anthony Speranzo Net Worth

The estimated Net Worth of Anthony J Speranzo is at least $386 Thousand dollars as of 21 May 2022. Mr. Speranzo owns over 5,151 units of R1 RCM stock worth over $356,389 and over the last 5 years he sold RCM stock worth over $0. In addition, he makes $30,000 as Independent Director at R1 RCM.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Speranzo RCM stock SEC Form 4 insiders trading

Anthony has made over 9 trades of the R1 RCM stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 5,151 units of RCM stock worth $72,732 on 21 May 2022.

The largest trade he's ever made was exercising 12,094 units of R1 RCM stock on 28 May 2021 worth over $170,767. On average, Anthony trades about 1,328 units every 31 days since 2019. As of 21 May 2022 he still owns at least 25,240 units of R1 RCM stock.

You can see the complete history of Mr. Speranzo stock trades at the bottom of the page.

Anthony Speranzo biography

Anthony J. Speranzo serves as Independent Director of the Company. Mr. Speranzo has been the Chief Executive Officer and President of Ascension Capital, LLC, Ascension’s healthcare investment fund, since July 2019. Prior to this role, Mr. Speranzo served as the Executive Vice President and Chief Financial Officer of Ascension, the parent corporation of Ascension Health, from the corporation’s formation in September 2011 until July 2019. From 2002 to September 2011, Mr. Speranzo served as the Senior Vice President and Chief Financial Officer of Ascension Health. Prior to joining Ascension Health, Mr. Speranzo served as Managing Director at U.S. Bancorp Piper Jaffray (USBPJ) in Newport Beach, California. Mr. Speranzo has also served on several hospital and corporate boards. Mr. Speranzo is an Investor Designee.

What is the salary of Anthony Speranzo?

As the Independent Director of R1 RCM, the total compensation of Anthony Speranzo at R1 RCM is $30,000. There are 11 executives at R1 RCM getting paid more, with Joseph Flanagan having the highest compensation of $4,859,860.

How old is Anthony Speranzo?

Anthony Speranzo is 71, he's been the Independent Director of R1 RCM since 2017. There are 2 older and 13 younger executives at R1 RCM. The oldest executive at R1 RCM Inc. is Michael Feiner, 77, who is the Independent Director.

What's Anthony Speranzo's mailing address?

Anthony's mailing address filed with the SEC is C/O R1 RCM INC., 433 W. ASCENSION WAY, SUITE 200, MURRAY, UT, 84123.

Insiders trading at R1 RCM

Over the last 8 years, insiders at R1 RCM have traded over $770,079,900 worth of R1 RCM stock and bought 103,238 units worth $1,376,421 . The most active insiders traders include Achi Series Lllptcp Asc Gp,..., Joseph Gerard Flanagan, and John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of $7,812,780. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth $143,959.

What does R1 RCM do?

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Complete history of Mr. Speranzo stock trades at R1 RCM

R1 RCM executives and stock owners

R1 RCM executives and other stock owners filed with the SEC include:

• Joseph Flanagan,
  President, Chief Executive Officer, Director
• Gary Long,
  Executive Vice President, Chief Commercial Officer
• Joseph Gerard Flanagan,
  Pres, CEO & Director
• Gary S. Long,
  Exec. VP & Chief Commercial Officer
• Richard Evans,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Richard B. Evans Jr.,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Rachel Wilson,
  Exec. VP, CFO & Treasurer
• Alex Mandl,
  Lead Independent Director
• Michael Feiner,
  Independent Director
• Jill Smith,
  Independent Director
• John Henneman,
  Independent Director
• Anthony Tersigni,
  Director
• Anthony Speranzo,
  Independent Director
• Rachel Wilson,
  Chief Financial Officer, Treasurer
• Atif Rahim,
  Senior Vice President - Investor Relations & Business Development
• Vijay Kotte,
  Executive Vice President - Physician Services
• Ian Sacks,
  Independent Director
• Neal Moszkowski,
  Independent Director
• Albert Zimmerli,
  Director
• Vijay Kumar Kotte,
  Exec. VP of Strategy & Corp. Devel. and Chief Solutions Officer
• Sean Radcliffe,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Corey Perman,
  Exec. VP of Compliance & Risk
• Jay Sreedharan,
  Chief Technology & Digital Officer
• John M. Sparby,
  Exec. VP of Operations & Delivery and COO
• Charles J. Ditkoff,
  Director
• Steven J Shulman,
  Director
• Christopher Simon Ricaurte,
  Chief Financial Officer
• Mountain Capital, L.L.C.Coy...,
  
• Pamela L. Spikner,
  Principal Accounting Officer
• Thomas A Lesica,
  Chief Operating Officer
• Bradford Kyle Armbrester,
  Director
• Jeremy Delinsky,
  Director
• David M Dill,
  Director
• Scanlan Agnes Bundy,
  Director
• Lee Rivas,
  Chief Executive Officer
• John M. Sparby,
  President
• Jennifer D. Williams,
  Chief Financial Officer
• Kyle Hicok,
  Chief Commercial Officer